Mary Kay Inc. Named Among Most Reputable Global Employers in Reputation Institute’s 2019 Workplace Study
29.7.2019 18:00:00 EEST | Business Wire | Press release
Mary Kay Inc. is proud to be recognized in the 2019 Global Workplace 100 Study by Reputation Institute (Ri) as one of the world’s most reputable employers. Mary Kay is ranked number 42 among the top 100 global companies on the list.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190729005477/en/
“Our reputation among employees and customers is based on the foundation Mary Kay Ash established when she began her dream company in 1963,” said Melinda Foster Sellers, Chief People Officer at Mary Kay Inc. “She envisioned a company based on the Golden Rule that made the world a better place through corporate responsibility, innovation, ethical business practices and people-first management—all factors that contributed to our success in this year’s Reputation Institute study. We’re honored to be named among the most reputable employers from around the world in 2019.”
In the study, researchers at Reputation Institute—a leading provider of reputation measurement and management services—surveyed more than 230,000 individuals in 15 countries. Reputation Institute measured companies based on professional development, total rewards, work environment, market leadership, products and responsibility.
According to the research, over the last year, willingness to work for Mary Kay increased by 6.2 percent, the largest improvement among all the companies measured in the Global RepTrak® 100 study. Mary Kay outranks other global powerhouse brands in a variety of industries across the globe.
“Mary Kay is a rising star in the reputation study—showing the biggest improvement in the ‘willingness to work for’ category of all companies measured,” said Stephen Hahn-Griffiths, Chief Reputation Officer at Ri. “Companies like Mary Kay are reaping the benefits of building workplace cultures that foster inclusion while demonstrating concern for the health and well-being of its employees.”
This is the latest in the series of accolades Mary Kay has received highlighting its position as a global employer of choice. Other recent awards include:
- Top 10 Global CEOs: Reputation Institute named Chairman and CEO David Holl among the top 10 most reputable chief executives in the world according to its CEO RepTrak® 2019.
- Best Midsize Employer 2019: Recognized by Forbes as one of America’s Best Midsize Employers 2019. Mary Kay is ranked number 97 of the 500 companies on the list.
- Best Employer for Diversity 2019: Recognized by Forbes as one of America’s Best Employers for Diversity 2019. Mary Kay is ranked number 150 of the 500 companies on the list.
- Global Excellence in the Workplace: Mary Kay Spain and Mary Kay Poland earned the 2018 AON Best Employers Award, recognizing organizations demonstrating excellence in the workplace. Mary Kay China and Mary Kay Mexico picked up the honor in 2017.
- Family-Friendly Employer 2018: Mary Kay Hong Kong was recognized by Home Affairs Bureau as a top family-friendly employer.
- Chinese Enterprise Health Management Top 10 Employers 2018: China International Intellectech Corporation honored Mary Kay China.
About Mary Kay
One of the original glass ceiling breakers, Mary Kay Ash founded her beauty company more than 55 years ago with three goals: offer rewarding opportunities for women, provide irresistible products and make the world a better place. That dream has blossomed into a multibillion-dollar company with millions of independent sales force members in nearly 40 countries. Mary Kay is dedicated to researching the science behind beauty and to manufacturing cutting-edge skin care, color cosmetics, fragrances and nutritional supplements. Through The Mary Kay FoundationSM, the company has awarded more than $78 million to cancer research and domestic violence shelters. Mary Kay Ash’s original vision continues to shine—one lipstick at a time.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190729005477/en/
Contact information
Mary Kay Inc. Corporate Communications
marykay.com/newsroom
972.687.5332 or media@mkcorp.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Carnegie Mellon University and Cleveland Clinic Develop AI System to Interpret Cardiac MRI Scans with Enhanced Accuracy21.5.2026 15:05:00 EEST | Press release
A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521762286/en/ A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. The novel system, called CMR-CLIP, is designed to interpret cardiac MRI scans by connecting moving images of the heart with corresponding clinical radio
The Live Moment Effect: Genius Sports and MediaScience Study Finds Specific Moments in Live Sports Can Double Unaided Brand Recall21.5.2026 15:00:00 EEST | Press release
Genius Sports Limited (NYSE: GENI), a global leader in real-time sports data, today released new biometric research conducted with MediaScience showing that ads delivered immediately after emotionally heightened moments in live sports can double unaided brand recall. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521475265/en/ The Live Moment Effect report from Genius Sports and MediaScience. The study, The Live Moment Effect, finds that advertising effectiveness is significantly influenced by a viewer’s emotional state immediately before an ad is shown. In controlled biometric testing, ads shown after high-intensity sporting moments, such as near-scoring plays or crucial momentum shifts, delivered approximately double the unaided brand recall of baseline conditions. The Moment Before the Ad Matters The research challenges long-held assumptions about media value, showing that not all impressions are equal. Live sports rem
Merck Announces First Patient Dosed in Phase 3 Study for Investigational Antibody-Drug Conjugate in Colorectal Cancer21.5.2026 15:00:00 EEST | Press release
Merck, a leading science and technology company, today announced that the first patient has been dosed in the Phase 3 PROCEADE®-CRC-03 trial (NCT07549412). The study is evaluating precemtabart tocentecan (Precem‑TcT), a potential first‑in‑class investigational anti‑CEACAM5 antibody‑drug conjugate (ADC), for the treatment of metastatic colorectal cancer (mCRC). “Leveraging our novel payload‑linker technology, Precem‑TcT is the first CEACAM5‑targeted ADC in clinical studies with an exatecan payload, rationally designed for stability and enhanced cancer cell killing activity,” said David Weinreich, MD, MBA, Global Head of R&D and Chief Medical Officer for the Healthcare business of Merck. “The Phase 3 study and the enrollment of the first patient with Precem-TcT build on the Company’s more than 20 years of expertise in colorectal cancer, and highlight our commitment to advancing differentiated ADCs for heavily pretreated patients with limited treatment options.” The PROCEADE®-CRC-03 study
Baszucki Group Funds Oxford University Clinical Trial of Ketogenic Therapy for Early Psychosis21.5.2026 14:00:00 EEST | Press release
Baszucki Group today announced a £1.17 million grant to support a randomized controlled trial at the University of Oxford assessing the feasibility, safety, and efficacy of a ketogenic diet for patients at clinical high risk of psychosis (CHR-P). Researchers will test this nutritional therapy's ability to improve patients' mental and physical health. This project builds on a growing body of research suggesting the potential of metabolic therapies in treating serious mental illness. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521877110/en/ Baszucki Group Funds £1.17 Million for University of Oxford Trial of Ketogenic Therapy for Early Psychosis Psychotic disorders carry a massive personal burden and are associated with a lower life expectancy. Psychosis does not develop immediately, but typically emerges following a period of early, subtle symptoms. Individuals in this stage, classified as CHR-P, represent a critical pr
SINOVAC Announces Extension of Deadline to Submit Payment Instructions for Previously Declared Special Cash Dividend21.5.2026 13:30:00 EEST | Press release
Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it has extended the deadline for shareholders and nominee brokers to submit payment instructions relating to the Company’s previously declared special cash dividend. The Company previously announced a special cash dividend of US$55.00 per common share, payable to valid holders of the Company’s common shares as of the close of business on May 23, 2025 ET. The Company previously informed shareholders that completed instruction materials were to be submitted prior to December 31, 2025 in order to facilitate receipt of the dividend. The Company has now extended that submission deadline to June 30, 2026. Shareholders and nominee brokers that have not yet submitted their instruction materials are reminded to do so on or before June 30, 2026 in order to facilitate payment of the dividend. If you have any questions regarding the process you need to un
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom